| Patricia Ann Neal, PHARM D | |
|
230 S L Rogers Wells Blvd, Glasgow, KY 42141-1129 | |
| (270) 651-7693 | |
| (847) 396-2712 |
| Full Name | Patricia Ann Neal |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Ambulatory Care |
| Location | 230 S L Rogers Wells Blvd, Glasgow, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437505666 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P2201X | Pharmacist - Ambulatory Care | 11539 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Patricia Ann Neal, PHARM D 126 Harold Poynter Rd, Knob Lick, KY 42154 Ph: (270) 646-7447 | Patricia Ann Neal, PHARM D 230 S L Rogers Wells Blvd, Glasgow, KY 42141-1129 Ph: (270) 651-7693 |
News Archive
In an Inter Press Service opinion piece, Siddharth Chatterjee, chief diplomat and head of strategic partnerships at the International Federation of Red Cross and Red Crescent Societies, and Sam Agbo, an independent public health adviser in the U.K., write about the unstable situation in Darfur, Sudan, in 2004, and how "UNICEF and WHO in Sudan along with important NGO partners started planning with local authorities on how best to immunize all children in Darfur."
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced plans to initiate a Phase 2 proof-of-concept clinical trial in the second half of 2010 to evaluate the effectiveness and safety of its oncology drug candidate bafetinib (formerly known as INNO-406) in patients with an advanced form of prostate cancer known as metastatic hormone-refractory prostate cancer.
Cleveland Clinic nephrologist Joseph Nally Jr., M.D., has been awarded a three-year, $720,000 grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) to study and develop approaches for disease management for patients with chronic kidney disease.
Transmitting sensory signals from prostheses to the nervous system helps leg amputees to perceive prosthesis as part of their body.
The U.S. Food and Drug Administration today approved a new use of Gleevec (imatinib) to treat children newly diagnosed with Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia (ALL).
› Verified 4 days ago
Travis Hudnall, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 415 Happy Valley Rd, Glasgow, KY 42141 Phone: 270-651-5159 | |
Dr. Chad Marion Reynolds, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1220 N Race St, Glasgow, KY 42141 Phone: 270-651-7627 Fax: 270-651-9261 | |
Dr. Adam Fife, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 301 Rogers Rd, Glasgow, KY 42141 Phone: 270-629-4300 | |
Tyler Wood, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 301 Industrial Dr, Glasgow, KY 42141 Phone: 800-727-5514 | |
Mrs. Rania Rizkalla, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 W Main St, Glasgow, KY 42141 Phone: 270-651-0471 | |
Shannon Cooke, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1001 W Main St, Glasgow, KY 42141 Phone: 270-651-0471 | |
Dr. Tiffany Huddleston, PHARM D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 301 Industrial Dr, Glasgow, KY 42141 Phone: 800-727-5514 Fax: 800-727-5518 |